Intermittent. Doctors and patients hate the injection frequency. Drug companies hate it to because it results in much lower compliance, i.e. patient hates getting jabbed in the eye monthly, so they don't comply fully with the correct treatment protocol.
- Forums
- ASX - By Stock
- Genentech success
Intermittent. Doctors and patients hate the injection frequency....
-
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add OPT (ASX) to my watchlist
(20min delay)
|
|||||
Last
35.0¢ |
Change
-0.010(2.78%) |
Mkt cap ! $382.0M |
Open | High | Low | Value | Volume |
35.5¢ | 36.5¢ | 35.0¢ | $934.4K | 2.624M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
10 | 230715 | 35.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
36.0¢ | 17816 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 220529 | 0.350 |
11 | 831442 | 0.345 |
20 | 323131 | 0.340 |
7 | 368925 | 0.335 |
6 | 125505 | 0.330 |
Price($) | Vol. | No. |
---|---|---|
0.370 | 43985 | 1 |
0.375 | 24450 | 2 |
0.380 | 145591 | 2 |
0.385 | 16756 | 2 |
0.390 | 7694 | 2 |
Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
Featured News
OPT (ASX) Chart |
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online